Omandac, Virginia B.
HRN: 18-66-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/08/2022
05/15/2022
IV
600
Q8
Avulsed Wound Right Leg
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes